Release 5 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v5.0.0: R5 - STU ). This is the current published version in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Example Medication/medexample015 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : No defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile Medication .

Generated Narrative: Medication medexample015

Resource Medication "medexample015"

code : Capecitabine 500mg oral tablet (Xeloda) ( RxNorm #213293) capecitabine 500 MG Oral Tablet [Xeloda]

marketingAuthorizationHolder : name : Organization Medication Manufacturer

doseForm : Tablet (basic dose form (qualifier value) ( SNOMED CT #385055001) form)

ingredient

Items

- Reference
* Substance Capecitabine (substance)

instance strength : false 500 mg (Details: UCUM codemg = 'mg') /1(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details: Orderable Drug Form codeTAB = 'Tablet')

Codes Instances

- Concept LotNumber ExpirationDate
* Capecitabine (substance) ( SNOMED CT #386906001) 9494788 2017-05-22

Generated Narrative: Organization #mmanu

strength name : 500 mg (Details: UCUM code mg = 'mg') /1(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet') Medication Manufacturer

Generated Narrative: Substance #sub04

Batches Codes

- LotNumber ExpirationDate Concept
* 9494788 2017-05-22 Capecitabine (substance)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.